Whole group (n = 127) | Direct dispatch (n = 29) | Request dispatch (n = 98) | p | |
---|---|---|---|---|
Non-HEMS interventions | ||||
Antiemetics | 24 | 3 | 21 | .28 |
Analgesiaa | 21 | 3 | 17 | .41 |
Atropine | 1 | 0 | 1 | .99 |
Dextrose 10% | 3 | 0 | 3 | .59 |
Naloxone | 7 | 1 | 6 | .69 |
Supraglottic airway device | 4 | 0 | 4 | .57 |
IV | 145 | 22 | 123 | .016 |
IO | 4 (HH) 5 (Tib) | 3 (HH) 1 (Tib) | 1(HH) 4(Tib) | .21 |
HEMS interventions | ||||
PHEA | 73 | 13 | 60 | .088 |
Indication for PHEA | ||||
Reduced GCS (n) | 55 | 12 | 43 | .29 |
Airway | 10 | 0 | 10 | |
Compromise (n) | ||||
Unmanageable (n) | 7 | 1 | 6 | |
Resp failure (n) | 1 | 0 | 1 | |
RSI regime: | ||||
3–2-1b | 59 | 8 | 46 | 1.00 |
1–1-1c | 10 | 0 | 10 | |
Other | 6 | 2 | 4 | |
Anticoagulant reversal | 1 | 0 | 1 | .99 |
Vasopressor therapy | 8 | 1 | 7 | .68 |
Antibiotics/ acyclovir | 11 | 0 | 11 | .067 |
Hypertonic saline | 27 | 0 | 27 | .007 |